Western blotting assay of transketolase concentration in human hemolysates.
Using a rabbit anti-human transketolase antiserum and Western blotting we can determine nanogram amounts of transketolase in human hemolysates quantitatively. Transketolase concentration in 18 apparently healthy subjects was 55.7 +/- 12.1 micrograms/g Hb (mean +/- SD). Transketolase concentration correlated positively with the enzyme activity both with and without in vitro addition of thiamin pyrophosphate. However, the former had a closer correlation (r = 0.8418, P less than 0.001) than the latter (r = 0.6703, P less than 0.01). A heavy drinker with an extremely low transketolase activity had proportionally low concentration to the activity. These results indicate that transketolase in hemolysates, whether it is holoenzyme or apoenzyme activated in vitro, has an identical specific activity among all subjects studied and that the reduced activity of transketolase in alcoholics is due to the reduced content of the enzyme protein. This method is applicable to study the dynamics and the abnormality of apotransketolase in human hemolysates.
D000428:Alcohol Drinking; D004586:Electrophoresis; D006461:Hemolysis; D006801:Humans; D007118:Immunoassay; D007142:Immunoglobulin gamma-Chains; D013835:Thiamine Pyrophosphate / Q000494:pharmacology; D014174:Transketolase / Q000097:blood* / Q000276:immunology
D007142:Immunoglobulin gamma-Chains; D014174:Transketolase; D013835:Thiamine Pyrophosphate